loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 8ead8c87 F5c3 4aba Bb99 1bc29e2f1551 Applno 20685 Form Capsule Oral Dosage Eq 200mg Base - Drug Product Composition: (alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt)

    Menu

    (alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt)

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,140Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20685 / DOSAGE - CAPSULE;ORAL - EQ 200MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    INDINAVIR SULFATE(UNII: 771H53976Q)
    (INDINAVIR ANHYDROUS - UNII:9MG78X43ZT)     		INDINAVIR ANHYDROUS400mg

    Inactive Ingredients

    Ingredient Name
    Avera McKennan Hospital
    Merck Sharp & Dohme Corp.
    ANHYDROUS LACTOSE(3SY5LH9PMK)
    GELATIN(2G86QN327L) 
    GELATIN, UNSPECIFIED(2G86QN327L) 
    MAGNESIUM STEARATE(70097M6I30)
    TITANIUM DIOXIDE(15FIX9V2JP)